Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about DSNKY
Recent news which mentions DSNKY
< Previous
1
2
Next >
Is Gilead Sciences a Good Stock to Buy Now?
February 06, 2023
Tickers
AZN
DSNKY
GILD
PFE
Tags
Recent Press Releases
GILD
Market News
From
Motley Fool
Daiichi Sankyo Seeks Approval In Japan For Its mRNA-Based COVID-19 Vaccine
January 13, 2023
Tickers
DSKYF
DSNKY
Tags
Benzinga
Eurasia
Health Care
From
Benzinga
AstraZeneca - Daiichi Sankyo's Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs
December 19, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
DSKYF
AZNCF
Health Care
From
Benzinga
AstraZeneca Highlights First Results From Datopotamab Study In Pretreated Breast Cancer Patients
December 09, 2022
Tickers
AZN
AZNCF
DSNKY
Tags
General
News
Large Cap
From
Benzinga
European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs
November 14, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
AZN
Biotech
MRK
From
Benzinga
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Analyst Color
Health Care
DSKYF
From
Benzinga
Why MacroGenics Stock Sank Today
September 12, 2022
Tickers
DSNKY
MGNX
Tags
Recent Press Releases
DSNKY
Market News
From
Motley Fool
This Cancer Focused Stock Has 60% Potential Upside, Bullish Analyst Says
September 12, 2022
Tickers
DSNKY
RAIN
Tags
Health Care
Trading Ideas
News
From
Benzinga
3 Top Stocks to Invest In Right Now
August 16, 2022
Tickers
AZN
DSNKY
HSY
MRK
Tags
DSNKY
Stocks to Buy
MSFT
From
InvestorPlace
Seagen Suffers Loss In Arbitration Dispute Over ADC Technology
August 15, 2022
Tickers
DSKYF
DSNKY
MRK
SGEN
Tags
Biotech
Market News
MRK
From
Benzinga
AstraZeneca-Daiichi's Flagship Breast Cancer Drug Improves Survival In Late-Stage Study
August 15, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Health Care
DSKYF
AZNCF
From
Benzinga
Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation
August 12, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
DSNKY
Large Cap
News
From
Benzinga
AstraZeneca's Dato-DXd-Based Combo Therapies Show Promising Activity In Lung Cancer Patients
August 09, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Large Cap
DSNKY
General
From
Benzinga
Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact
July 25, 2022
Tickers
AZN
DSNKY
ENVB
IBB
Tags
AZN
Biotech
KKR
From
Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
July 19, 2022
Tickers
ACAD
APLS
AVDL
AZN
Tags
JNJ
NVS
Movers
From
Benzinga
AstraZeneca's Enhertu Wins European Approval For Pretreated Breast Cancer Setting
July 19, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Benzinga
AZNCF
DSKYF
From
Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Tickers
ALPMF
ALPMY
AXSM
AZN
Tags
Benzinga
IPSEY
AZNCF
From
Benzinga
EMA's Advisory Committee Backs Approval For AstraZeneca's Targeted Breast Cancer Therapies
June 27, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
AZN
Biotech
Market News
From
Benzinga
This Cancer Drug's News Could Mean Another Blockbuster for AstraZeneca
June 14, 2022
Tickers
AZN
DSNKY
JEF
Tags
JEF
Recent Press Releases
AZN
From
Motley Fool
AstraZeneca-Daiichi Breast Cancer Drug Cuts Disease Progression Or Death Risk By Almost 50%
June 06, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Benzinga
Top Stories
Health Care
From
Benzinga
Daiichi Sankyo - AstraZeneca's Enhertu Receives Third Breakthrough Therapy Tag In Breast Cancer
April 27, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
General
News
Large Cap
From
Benzinga
The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu
April 19, 2022
Tickers
ACAD
AMGN
AZN
BTAI
Tags
Market News
COVID/19 Coronavirus
AMGN
From
Benzinga
Daiichi Sankyo - AstraZeneca's Enhertu Receives Priority Review In US For Lung Cancer
April 19, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
News
General
DSNKY
From
Benzinga
Seagen Wins $42M Patent Claim Against Daiichi In Cancer Drug Case
April 11, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
SGEN
Briefs
Market News
From
Benzinga
AstraZeneca's Enhertu Meets Primary Endpoint In HER2-Low Breast Cancer Setting
February 22, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Briefs
Movers
Market News
From
Benzinga
Esperion Chops 40% Workforce As Launch Of Cholesterol Medication Falters
October 18, 2021
Tickers
AMGN
DSKYF
DSNKY
ESPR
Tags
Earnings
Biotech
ESPR
From
Benzinga
Here's Why Everyone's Talking About AstraZeneca Right Now
September 21, 2021
Tickers
AZN
DSNKY
RHHBY
Tags
AZN
RHHBY
DSNKY
From
Motley Fool
AstraZeneca's Enhertu Posts Substantial Clinical Benefit Over Roche's Kadcyla In Breast Cancer Trials
September 20, 2021
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Long Ideas
Market News
Movers
From
Benzinga
AstraZeneca-Daiichi Sankyo Share Detailed Enhertu Data In Gastric Cancer
September 17, 2021
Tickers
AZN
DSKYF
DSNKY
Tags
Phase 2 Trial
AZN
Biotech
From
Benzinga
Fraud Allegations Are Unlikely to Keep Cassava Stock Down
September 03, 2021
Tickers
DSNKY
PFE
SAVA
Tags
Market News
SAVA
Stocks to Buy
From
InvestorPlace
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.